Soleus Capital Management, L.P. Imago Bio Sciences, Inc. Transaction History

Soleus Capital Management, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$15.03 - $35.96 $1.47 Million - $3.52 Million	-98,000 Reduced 46.01%	115,000 $4.13 Million
Q3 2022 Nov 14, 2022	BUY	$14.15 - $19.5 $3.01 Million - $4.15 Million	213,000 New	213,000 $3.21 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.